The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Kv1.3 potassium channels as a therapeutic target in multiple sclerosis
Abstract
We discuss the potential use of inhibitors of Kv1.3 potassium channels in T lymphocytes as therapeutics for multiple sclerosis. Current treatment strategies target the immune system in a non-selective manner. The resulting general immunosuppression, toxic side-effects and increased risk of opportunistic infections create the need for more selective therapeutics. Autoreactive effector-memory T (T(EM)) cells, considered to be major mediators of autoimmunity, express large numbers of Kv1.3 channels. Selective blockers of Kv1.3 inhibit calcium signaling, cytokine production and proliferation of T(EM) cells in vitro, and T(EM) cell-motility in vivo. Kv1.3 blockers ameliorate disease in animal models of multiple sclerosis, rheumatoid arthritis, type 1 diabetes mellitus and contact dermatitis without compromising the protective immune response to acute infections. Kv1.3 blockers have a good safety profile in rodents and primates.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Kv1.3 channels are highly expressed by pro-inflammatory microglia in mouse models of refractory seizures as well as radiation neurotoxicity and recently, Kv1.3 blockade by Pap1 was shown to have amyloid-lowering and neuroprotective effects in AD mouse models [26, 48, 49, 51, 62, 63].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [63]
In the citing paper
“Kv1.3 channels are highly expressed by pro-inflammatory microglia in mouse models of refractory seizures as well as radiation neurotoxicity and recently, Kv1.3 blockade by Pap1 was shown to have amyloid-lowering and neuroprotective effects in AD mouse models [26, 48, 49, 51, 62, 63].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [63]
Citations
Cites
The Structure of the Potassium Channel: Molecular Basis of K + Conduction and Selectivity
Doyle, D. A., Cabral, J. M., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., Chait, B. T., & MacKinnon, R. (1998) · Science · doi:10.1126/science.280.5360.69 · Cited by 6,807
Crystal Structure of a Mammalian Voltage-Dependent Shaker Family K + Channel
Long, S. B., Campbell, E. B., & MacKinnon, R. (2005) · Science · doi:10.1126/science.1116269 · Cited by 2,124
STIM1, an essential and conserved component of store-operated Ca2 + channel function
Roos, J., DiGregorio, P. J., Yeromin, A. V., Ohlsen, K., Lioudyno, M., Zhang, S., Safrina, O., Kozak, J. A., Wagner, S. L., Cahalan, M. D., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200502019 · Cited by 1,828
Zhang, S. L., Yu, Y., Roos, J., Kozak, J. A., Deerinck, T. J., Ellisman, M. H., Stauderman, K. A., & Cahalan, M. D. (2005) · Nature · doi:10.1038/nature04147 · Cited by 1,389
Orai1 is an essential pore subunit of the CRAC channel
Prakriya, M., Feske, S., Gwack, Y., Srikanth, S., Rao, A., & Hogan, P. G. (2006) · Nature · doi:10.1038/nature05122 · Cited by 1,343 · cited 1×
“Emptying of internal calcium stores promotes the co-assembly of stromal interaction molecule 1 (Stim1) and Orai1 proteins into a membrane complex that constitutes the calcium-release activated calcium (CRAC) channel [51,53,55-62].”
BackgroundDendritic cells in a mature age
Reis e Sousa, C. (2006) · Nature Reviews Immunology · doi:10.1038/nri1845 · Cited by 1,195 · cited 1×
“Dendritic cells may also directly attack oligodendrocytes and neurons [14].”
BackgroundSørensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 1,002
Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?
DeCoursey, T. E., Chandy, K. G., Gupta, S., & Cahalan, M. D. (1984) · Nature · doi:10.1038/307465a0 · Cited by 744 · cited 3×
“3 channels in T cells and suppressed T cell proliferation with parallel potency [20].”
BackgroundSelf-citationLuik, R. M., Wu, M. M., Buchanan, J., & Lewis, R. S. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200604015 · Cited by 644 · cited 1×
“Emptying of internal calcium stores promotes the co-assembly of stromal interaction molecule 1 (Stim1) and Orai1 proteins into a membrane complex that constitutes the calcium-release activated calcium (CRAC) channel [51,53,55-62].”
BackgroundA human intermediate conductance calcium-activated potassium channel
Ishii, T. M., Silvia, C., Hirschberg, B., Bond, C. T., Adelman, J. P., & Maylie, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11651 · Cited by 612 · cited 1×
“1 (also known as KCNN4 or IKCa1) [32-34] The functional channel is composed of four KCa3.”
Background
Research works printed but not linked: 8
- Grissmer, 1988, A marker for lymphoproliferative diseases? J Immunol, 141, 1137
- Sallusto, 2000, Curr Top Microbiol Immunol, 251, 167
- Bohuslavizki, 1992, Gen Physiol Biophys, 11, 507
- Fdez-Freire, 2005, J Drugs Dermatol, 4, 374
- Arkett, 1994, Receptors Channels, 2, 281
- Manabe, 1998, Res Commun Mol Pathol Pharmacol, 99, 33
- Mathew, 2006, Trop Gastroenterol, 27, 87
- Viglietta, 2002, J Clin Invest, 109, 895, 10.1172/JCI0214114 · doi:10.1172/jci0214114 · Paper page
Cited by
Rangaraju, S., Dammer, E. B., Raza, S. A., Rathakrishnan, P., Xiao, H., Gao, T., Duong, D. M., Pennington, M. W., Lah, J. J., Seyfried, N. T., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0254-8 · Cited by 430
“shown to have amyloid-lowering and neuroprotective effects in AD mouse models [26, 48, 49, 51, 62, 63].”
BackgroundSelf-citationAbdollahi, E., Momtazi, A. A., Johnston, T. P., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25778 · Cited by 270
“This channel has a key role in the severity of some autoimmune diseases, such as MS and RA [148, 149].”
BackgroundK+Channels: Function‐Structural Overview
González, C., Baez‐Nieto, D., Valencia, I., Oyarzún, I., Rojas, P., Naranjo, D., & Latorre, R. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110047 · Cited by 223
“3 inhibitors inhibit calcium signaling, cytokine production, and proliferation of T-cells in vitro, and T-cell-motility in vivo (444).”
The voltage-dependent K+ channels Kv1.3 and Kv1.5 in human cancer
Comes, N., Bielańska, J., Vallejo-Gracia, A., Serrano-Albarrás, A., Marruecos, L., Gómez, D., Soler, C., Condom, E., y Cajal, S. R., Hernández‐Losa, J., et al. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00283 · Cited by 143
“To date, several important differences in Kv expression during neonatal development have been reported (Roberds and Tamkun, 1991; Lesage et al., 1992; Felipe et al., 1994; Coma et al., 2002; Grande et al., 2003; Tsevi et al., 2005).”
BackgroundPotassium Channel Kv1.3 Is Highly Expressed by Microglia in Human Alzheimer's Disease
Rangaraju, S., Gearing, M., Jin, L.-W., & Levey, A. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141704 · Cited by 137
“1) have been found to regulate cellular functions limited to distinct cell subsets that mediate autoimmunity, a finding of therapeutic relevance in human disease [9, 21].”
BackgroundSelf-citation
Metadata
- Authors
- Rangaraju, S., Chi, V., Pennington, M. W., & Chandy, K. G.
- Affiliations
- University of California, Irvine (US)
- Venue
- Expert Opinion on Therapeutic Targets
- Publisher
- Informa UK Limited
- Published
- 2009-06-20
- Volume
- 13
- Issue
- 8
- Pages
- 909-924
- ISSN
- 1472-8222 (ISSN-L)
- 1744-7631
- OpenAlex
- W2014156502
- Cited by
- 99
- References
- 154
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 9 · 2015: 8 · 2014: 4 · 2013: 5 · 2012: 11
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Therapeutic Targets (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS-048252, R01NS048252)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- Kv1.3 potassium channel, multiple sclerosis, T cells, effector memory T cells, autoimmunity, immunosuppression, T cell proliferation, T cell motility, calcium signaling, rheumatoid arthritis, type 1 diabetes, contact dermatitis, drug safety
- MeSH terms
- Animals, Humans, Multiple Sclerosis, T-Lymphocytes, Cytokines, Drug Delivery Systems, Potassium Channel Blockers, Cell Proliferation, Kv1.3 Potassium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. https://app.cochat.ai/papers/10.1517/14728220903018957
- The paper
- Rangaraju, S., Chi, V., Pennington, M. W., & Chandy, K. G. (2009). Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. Expert Opinion on Therapeutic Targets. https://doi.org/10.1517/14728220903018957
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.